Pipeline

women shaking hands during partnership agreement
 
Well-Rounded

Recent acquisitions and our ongoing expansion efforts have laid the groundwork for a robust product pipeline. With an accelerated commitment to enhancing our capabilities with additional dose forms and a focus on novel development and ANDA manufacturing, our pipeline is well-rounded and continues to grow.

 


There's plenty on the horizon for Chartwell Pharmaceuticals LLC:



1

Multiple ANDAs
in development

2

ANDAs
pending filing

3

Capabilities for additional dosage forms currently being built out

4

Development of additional 505(b)2 products underway



Explore our existing portfolio by visiting the Generics Catalog and reading more about our Branded Products.
Chartwell Pharmaceuticals
Well-Done.